Gynecomastia Protocol — Author’s Field Report & PDF Guide
Samir Levin’s documented approach, with the oral and topical schedules, preparation steps, risk notes and follow-up timeline collected in one PDF.
4 pages including the cover · 11 sections · v2.2, April 2026.
PDF contents
| Section | Contents | PDF pages |
|---|
| Introduction and author’s criteria | Overview, summary, the author’s selection observations and disclaimer. | 2 |
| Oral and topical schedules | Serrapeptase, Nattokinase and DIM; DMSO, castor oil and capsule powder, with the amounts and timing described by the author. | 2–3 |
| Preparation and application | Morning oral schedule and step-by-step mixing and topical application. | 3 |
| Author-reported follow-up timeline | The document’s stages: weeks 3–4, month 2, months 3–4 and months 5–6+. | 4 |
| Conditions and risk notes | Underlying causes, anticoagulant and DMSO cautions, skin irritation and pausing. | 4 |
| 4 PDF FAQs | Surgery, no noticeable effect after two months, increasing doses and breaks. | 4 |
Author’s field report
Samir describes gynecomastia beginning in puberty and worsening with anabolic-androgenic steroid use. He reports approximately 80% reduction in his own case without surgery. Samir Levin’s personal account.
Clinical assessment and the causes of gynecomastia are separate from the author’s field report. EAA and SIAMS guidelines discuss medical history, examination and cause-directed management; they do not establish this oral and topical schedule as a proven reversal treatment.
Clinical context: EAA 2019 and SIAMS 2026. These guidelines do not validate the author’s enzyme schedule or cold-response observation.
Questions
Is gynecomastia reversible without surgery?
It depends on the cause and stage. EAA describes spontaneous resolution in many pubertal cases and observation after an underlying cause is treated or an aggravating substance is stopped; persistent, long-standing cases may require surgery. Samir reports approximately 80% reduction in his own long-standing AAS-associated case without surgery.
What do I receive?
A 4-page PDF including the cover: v2.2, April 2026, with 11 sections. It collects oral and topical schedules, amounts and timing, preparation and application steps, follow-up stages, risk notes and 4 FAQ answers.
What is the timeline?
The author-reported PDF timeline has four stages: weeks 3–4 — increased sensitivity, possible mild discomfort or itching; month 2 — tissue softening and first visible volume reduction; months 3–4 — significant reduction; months 5–6+ — stabilization.
Does diet remove glandular tissue?
Gynecomastia involves glandular tissue, whereas pseudogynecomastia is fat accumulation; changing body fat is not the same as removing glandular tissue. The PDF lists reducing body fat, addressing hormonal causes and eliminating triggers among the author’s conditions, and includes a DIM schedule. It is not a diet plan.
Is nipple sensitivity or a cold response a useful test?
The author used those observations when describing his participants. Cold response and tenderness are not established tests of whether this schedule will work; pain can also be a symptom of gynecomastia.
What if there is no noticeable effect after 2 months?
The PDF’s author suggests two possible explanations: long-standing fibrotic tissue or an underlying cause that has not been addressed. The risk section also explains when to reduce the topical concentration or pause because of irritation or unusual reactions.
Can I increase the doses for faster results?
The author’s answer is no: increasing doses does not improve results in his schedule and only increases risks. The PDF gives the amounts and timing for the oral and topical components.
Are breaks from the protocol needed?
The author’s FAQ says breaks are not required if tolerance is good. The risk notes separately say to reduce the topical concentration or pause if irritation or unusual reactions occur.
Price: $25. PDF by email after payment · One-time payment · No subscription.